Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients.

ABSTRACT:

SUBMITTER: He R 

PROVIDER: S-EPMC8789920 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature